Tissue microarrays for high-throughput molecular profiling of tumor specimens - PubMed (original) (raw)
Tissue microarrays for high-throughput molecular profiling of tumor specimens
J Kononen et al. Nat Med. 1998 Jul.
Abstract
Many genes and signalling pathways controlling cell proliferation, death and differentiation, as well as genomic integrity, are involved in cancer development. New techniques, such as serial analysis of gene expression and cDNA microarrays, have enabled measurement of the expression of thousands of genes in a single experiment, revealing many new, potentially important cancer genes. These genome screening tools can comprehensively survey one tumor at a time; however, analysis of hundreds of specimens from patients in different stages of disease is needed to establish the diagnostic, prognostic and therapeutic importance of each of the emerging cancer gene candidates. Here we have developed an array-based high-throughput technique that facilitates gene expression and copy number surveys of very large numbers of tumors. As many as 1000 cylindrical tissue biopsies from individual tumors can be distributed in a single tumor tissue microarray. Sections of the microarray provide targets for parallel in situ detection of DNA, RNA and protein targets in each specimen on the array, and consecutive sections allow the rapid analysis of hundreds of molecular markers in the same set of specimens. Our detection of six gene amplifications as well as p53 and estrogen receptor expression in breast cancer demonstrates the power of this technique for defining new subgroups of tumors.
Comment in
- Full speed ahead for tumor screening.
Theillet C. Theillet C. Nat Med. 1998 Jul;4(7):767-8. doi: 10.1038/nm0798-767. Nat Med. 1998. PMID: 9662361 No abstract available.
Similar articles
- Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer.
Zhang D, Salto-Tellez M, Putti TC, Do E, Koay ES. Zhang D, et al. Mod Pathol. 2003 Jan;16(1):79-84. doi: 10.1097/01.MP.0000047307.96344.93. Mod Pathol. 2003. PMID: 12527717 - Microcysts and breast cancer: a study of biological markers in archival biopsy material.
Tran DD, Lawson JS. Tran DD, et al. Breast Cancer Res Treat. 2002 Oct;75(3):213-20. doi: 10.1023/a:1019969730552. Breast Cancer Res Treat. 2002. PMID: 12353810 - Triple-negative breast cancer: current state of the art.
Rastelli F, Biancanelli S, Falzetta A, Martignetti A, Casi C, Bascioni R, Giustini L, Crispino S. Rastelli F, et al. Tumori. 2010 Nov-Dec;96(6):875-88. Tumori. 2010. PMID: 21388048 Review. - High-throughput microarray technologies: from genomics to clinics.
Bubendorf L. Bubendorf L. Eur Urol. 2001 Aug;40(2):231-8. doi: 10.1159/000049777. Eur Urol. 2001. PMID: 11528203 Review.
Cited by
- Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder.
Furlano K, Plage H, Hofbauer S, Weinberger S, Ralla B, Fendler A, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Koch S, Adamini N, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Zecha H. Furlano K, et al. BJUI Compass. 2024 Sep 10;5(11):1081-1089. doi: 10.1002/bco2.431. eCollection 2024 Nov. BJUI Compass. 2024. PMID: 39539567 Free PMC article. - Prevalence and Significance of AGR2 Expression in Human Cancer.
Schraps N, Port JC, Menz A, Viehweger F, Büyücek S, Dum D, Schlichter R, Hinsch A, Fraune C, Bernreuther C, Kluth M, Hube-Magg C, Möller K, Reiswich V, Luebke AM, Lebok P, Weidemann S, Sauter G, Lennartz M, Jacobsen F, Clauditz TS, Marx AH, Simon R, Steurer S, Mercanoglu B, Melling N, Hackert T, Burandt E, Gorbokon N, Minner S, Krech T, Lutz F. Schraps N, et al. Cancer Med. 2024 Nov;13(21):e70407. doi: 10.1002/cam4.70407. Cancer Med. 2024. PMID: 39533806 Free PMC article. - Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer.
Hjelmeland ME, Lien HE, Berg HF, Woie K, Werner HMJ, Amant F, Haldorsen IS, Trovik J, Krakstad C. Hjelmeland ME, et al. BJC Rep. 2024 Oct 18;2(1):81. doi: 10.1038/s44276-024-00105-2. BJC Rep. 2024. PMID: 39516342 Free PMC article. - Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors.
Lutz F, Han SY, Büyücek S, Möller K, Viehweger F, Schlichter R, Menz A, Luebke AM, Bawahab AA, Reiswich V, Kluth M, Hube-Magg C, Hinsch A, Weidemann S, Lennartz M, Dum D, Bernreuther C, Lebok P, Sauter G, Marx AH, Simon R, Krech T, Fraune C, Gorbokon N, Burandt E, Minner S, Steurer S, Clauditz TS, Jacobsen F. Lutz F, et al. Diagnostics (Basel). 2024 Sep 28;14(19):2157. doi: 10.3390/diagnostics14192157. Diagnostics (Basel). 2024. PMID: 39410561 Free PMC article. - TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities.
Möller K, Gulzar T, Lennartz M, Viehweger F, Kluth M, Hube-Magg C, Bernreuther C, Bawahab AA, Simon R, Clauditz TS, Sauter G, Schlichter R, Hinsch A, Kind S, Jacobsen F, Burandt E, Frost N, Reck M, Marx AH, Krech T, Lebok P, Fraune C, Steurer S. Möller K, et al. Virchows Arch. 2024 Nov;485(5):815-828. doi: 10.1007/s00428-024-03926-1. Epub 2024 Oct 8. Virchows Arch. 2024. PMID: 39377914 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous